產(chǎn)品編號(hào) | Ys-0971R |
英文名稱(chēng) | Chloramphenicol |
中文名稱(chēng) | 氯霉素抗體 |
別 名 | Chloramphenicol; D-(−)-threo-2,2-Dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-beta-(4-nitrophenyl)ethyl]acetamide, D-(−)-threo-2-Dichloroacetamido-1-(4-nitrophenyl)-1,3-propanediol, D-threo-2,2-Dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-4-nitrophenethyl]acetamide, Chloromycetin. |
產(chǎn)品類(lèi)型 | 小分子抗體 |
研究領(lǐng)域 | 藥物及化合物 |
抗體來(lái)源 | Rabbit |
克隆類(lèi)型 | Polyclonal |
產(chǎn)品應(yīng)用 | ELISA=1:5000-10000 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理論分子量 | 0.32313kDa |
性 狀 | Liquid |
濃 度 | 1mg/ml |
免 疫 原 | KLH conjugated Chloramphenicol |
亞 型 | IgG |
純化方法 | affinity purified by Protein A |
緩 沖 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
保存條件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
產(chǎn)品介紹 | Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae, isolated by David Gottlieb, and introduced into clinical practice in 1949. It was the first antibiotic to be manufactured synthetically on a large scale, and alongside the tetracyclines, is considered the prototypical broad-spectrum antibiotic. Chloramphenicol is effective against a wide variety of Gram-positive and Gram-negative bacteria, including most anaerobic organisms. Due to resistance and safety concerns, it is no longer a first-line agent for any indication in developed nations and has been replaced by newer drugs in this setting, although it is sometimes used topically for eye infections. In low-income countries, chloramphenicol is still widely used because it is exceedingly inexpensive and readily available. |
我要詢價(jià)
*聯(lián)系方式:
(可以是QQ、MSN、電子郵箱、電話等,您的聯(lián)系方式不會(huì)被公開(kāi))
*內(nèi)容: